Kairos Pharma KAPA Q3 2025 earnings

FAQ

When did Kairos Pharma report Q3 2025 earnings?

Kairos Pharma (KAPA) reported Q3 2025 earnings on November 14, 2025 before market open.

What were Kairos Pharma's Q3 2025 revenue and EPS?

Kairos Pharma reported eps of $-0.07 for Q3 2025.

Did Kairos Pharma beat estimates in Q3 2025?

EPS beat the consensus estimate of $-0.10 by $0.03.

How did Kairos Pharma's Q3 2025 results compare year-over-year?

Compared to the same quarter a year prior, eps grew 30.0% from $-0.10.

Where can I find Kairos Pharma's Q3 2025 SEC filings?

You can read the 10-Q periodic report (0001493152-25-023276) directly on SEC EDGAR. The filing index links above go to sec.gov.